Rebranding efforts include a new logo, overall brand presence, and corporate design.

This marks Marius Pharmaceuticals’ fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company’s ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on aTyr Pharma (ATYR – Research Report) today and set a price target of $20.00. The company’s shares closed yesterday at $3.99.

Zydus Lifesciences is planning to acquire European medical technology company Amplitude Surgical ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex ...

The exports of the Indian pharmaceutical sector have witnessed a solid performance ... producing generic versions of high-demand drugs such as Revlimid and Mirabegron. Zydus Life has reported an ...

March 11 (Reuters) - India's Zydus Lifesciences (ZYDU.NS), opens new tab said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA), opens new tab for 256.8 million ...

Zydus Lifesciences received approval from the USFDA to market Ketoconazole Shampoo, an antifungal medication, in the US. This approval is for a generic version targeting dandruff and various fungal ...

chairman of Zydus Lifesciences Ltd on Monday said Government on India was working on a new incentive policy for pharmaceutical research that will help many Indian companies take up Research ...

Zydus Lifesciences received the final approval from the United ... surfactants and specialty ingredients plant at an overseas location. IOL Chemicals & Pharmaceuticals received a certificate of ...

Ahmedabad: Global lifesciences company, Zydus Lifesciences Limited ... She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma ...